GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ZYUS Life Sciences Corp (TSXV:ZYUS) » Definitions » Construction In Progress

ZYUS Life Sciences (TSXV:ZYUS) Construction In Progress : C$0.00 Mil (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is ZYUS Life Sciences Construction In Progress?

ZYUS Life Sciences's quarterly construction in progress declined from Dec. 2023 (C$0.69 Mil) to Mar. 2024 (C$0.00 Mil) but then stayed the same from Mar. 2024 (C$0.00 Mil) to Jun. 2024 (C$0.00 Mil).

ZYUS Life Sciences's annual construction in progress increased from Dec. 2021 (C$0.00 Mil) to Dec. 2022 (C$0.68 Mil) and increased from Dec. 2022 (C$0.68 Mil) to Dec. 2023 (C$0.69 Mil).


ZYUS Life Sciences Construction In Progress Historical Data

The historical data trend for ZYUS Life Sciences's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ZYUS Life Sciences Construction In Progress Chart

ZYUS Life Sciences Annual Data
Trend Dec21 Dec22 Dec23
Construction In Progress
- 0.68 0.69

ZYUS Life Sciences Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - 0.69 - -

ZYUS Life Sciences Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.


ZYUS Life Sciences Business Description

Traded in Other Exchanges
Address
407 Downey Road, Unit 204, Saskatoon, SK, CAN, S7N 4L8
ZYUS Life Sciences Corp is a next-generation life sciences company engaged in scientific research and development in phyto-therapeutics, including cannabinoid and protein-based formulations. It is committed to delivering high-quality standardized therapeutic formulations that comply with Good Manufacturing Practices (GMP) to provide targeted relief for patients in Canada and globally.
Executives
John Michael Hyshka Senior Officer

ZYUS Life Sciences Headlines

No Headlines